IFITM1 and ovarian carcinoma: IFITM1 (interferon-induced transmembrane protein 1) is an immune response-related protein whose epigenetically regulated overexpression promotes migration, invasion, and metastasis in ovarian cancer, and methylation of the IFITM1 promoter may be a biomarker of progression [62].